483 related items for PubMed ID: 17973974
1. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
Leventer SM, Raudibaugh K, Frissora CL, Kassem N, Keogh JC, Phillips J, Mangel AW.
Aliment Pharmacol Ther; 2008 Jan 15; 27(2):197-206. PubMed ID: 17973974
[Abstract] [Full Text] [Related]
2. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
[Abstract] [Full Text] [Related]
3. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
Mangel AW, Bornstein JD, Hamm LR, Buda J, Wang J, Irish W, Urso D.
Aliment Pharmacol Ther; 2008 Jul 15; 28(2):239-49. PubMed ID: 18466359
[Abstract] [Full Text] [Related]
4. Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome.
Chey WD, Chey WY, Heath AT, Dukes GE, Carter EG, Northcutt A, Ameen VZ.
Am J Gastroenterol; 2004 Nov 15; 99(11):2195-203. PubMed ID: 15555002
[Abstract] [Full Text] [Related]
5. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
Chang L, Ameen VZ, Dukes GE, McSorley DJ, Carter EG, Mayer EA.
Am J Gastroenterol; 2005 Jan 15; 100(1):115-23. PubMed ID: 15654790
[Abstract] [Full Text] [Related]
6. Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome.
Zakko S, Barton G, Weber E, Dunger-Baldauf C, Rühl A.
Aliment Pharmacol Ther; 2011 Jun 15; 33(12):1311-21. PubMed ID: 21507028
[Abstract] [Full Text] [Related]
7. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R, Nikfar S, Abdollahi M.
Clin Ther; 2008 May 15; 30(5):884-901. PubMed ID: 18555935
[Abstract] [Full Text] [Related]
8. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
Chang FY, Lu CL, Chen CY, Luo JC.
J Gastroenterol Hepatol; 2007 Dec 15; 22(12):2266-72. PubMed ID: 17559369
[Abstract] [Full Text] [Related]
9. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
Gastroenterol Clin Biol; 2008 Feb 15; 32(2):147-52. PubMed ID: 18387426
[Abstract] [Full Text] [Related]
10. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.
Krause R, Ameen V, Gordon SH, West M, Heath AT, Perschy T, Carter EG.
Am J Gastroenterol; 2007 Aug 15; 102(8):1709-19. PubMed ID: 17509028
[Abstract] [Full Text] [Related]
11. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA.
Am J Gastroenterol; 2008 May 15; 103(5):1217-25. PubMed ID: 18477346
[Abstract] [Full Text] [Related]
12. Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.
Tack JF, Miner PB, Fischer L, Harris MS.
Aliment Pharmacol Ther; 2011 Oct 15; 34(8):868-77. PubMed ID: 21883322
[Abstract] [Full Text] [Related]
13. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ.
Am J Gastroenterol; 2010 Jan 15; 105(1):170-7. PubMed ID: 19809408
[Abstract] [Full Text] [Related]
14. A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome.
Camilleri M, Kim DY, McKinzie S, Kim HJ, Thomforde GM, Burton DD, Low PA, Zinsmeister AR.
Clin Gastroenterol Hepatol; 2003 Mar 15; 1(2):111-21. PubMed ID: 15017503
[Abstract] [Full Text] [Related]
15. Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome.
Olden K, DeGarmo RG, Jhingran P, Bagby B, Decker C, Markowitz M, Carter E, Bobbitt W, Dahdul A, DeCastro E, Gringeri L, Johanson J, Levinson L, Mula G, Poleynard G, Stoltz RR, Truesdale R, Young D, Lotronex Investigator Team.
Am J Gastroenterol; 2002 Dec 15; 97(12):3139-46. PubMed ID: 12492201
[Abstract] [Full Text] [Related]
16. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
Leung WK, Wu JC, Liang SM, Chan LS, Chan FK, Xie H, Fung SS, Hui AJ, Wong VW, Che CT, Sung JJ.
Am J Gastroenterol; 2006 Jul 15; 101(7):1574-80. PubMed ID: 16863563
[Abstract] [Full Text] [Related]
17. Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome.
Lembo T, Wright RA, Bagby B, Decker C, Gordon S, Jhingran P, Carter E, Lotronex Investigator Team.
Am J Gastroenterol; 2001 Sep 15; 96(9):2662-70. PubMed ID: 11569692
[Abstract] [Full Text] [Related]
18. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
Clavé P, Acalovschi M, Triantafillidis JK, Uspensky YP, Kalayci C, Shee V, Tack J, OBIS Study Investigators.
Aliment Pharmacol Ther; 2011 Aug 15; 34(4):432-42. PubMed ID: 21679214
[Abstract] [Full Text] [Related]
19. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome.
Vahedi H, Merat S, Momtahen S, Kazzazi AS, Ghaffari N, Olfati G, Malekzadeh R.
Aliment Pharmacol Ther; 2008 Apr 15; 27(8):678-84. PubMed ID: 18248658
[Abstract] [Full Text] [Related]
20. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS.
Gastroenterology; 2013 Aug 15; 145(2):329-38.e1. PubMed ID: 23583433
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
